» Articles » PMID: 15781629

Immortalization of Primary Human Prostate Epithelial Cells by C-Myc

Overview
Journal Cancer Res
Specialty Oncology
Date 2005 Mar 23
PMID 15781629
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

A significant percentage of prostate tumors have amplifications of the c-Myc gene, but the precise role of c-Myc in prostate cancer is not fully understood. Immortalization of human epithelial cells involves both inactivation of the Rb/p16INK4a pathway and telomere maintenance, and it has been recapitulated in culture by expression of the catalytic subunit of telomerase, hTERT, in combination with viral oncoproteins. Here, we show the immortalization of human prostate epithelial cells (HPrEC) by a single genetic event, the expression of the c-Myc oncogene. Myc stabilizes telomere length in HPrEC through up-regulation of hTERT expression and overrides the accumulation of cell cycle inhibitory proteins, such as p16INK4a. Overall, HPrECs expressing c-Myc retain many characteristics of normal cells, such as the induction of a senescence-like growth arrest in response to oncogenic Ras, an intact p53 response, and an absence of gross karyotypic abnormalities. However, HPrECs expressing c-Myc lack a Rb/p16INK4a checkpoint and can be transformed without the need for additional genetic lesions in that pathway. These results give a partial explanation for the physiologic role of c-Myc overexpression in prostate cancer.

Citing Articles

Rejuvenation of human mesenchymal stem cells using a nonintegrative and conditionally removable Sendai virus vector.

Oshimura M, Tabata T, Uno N, Takata S, Hichiwa G, Kanazawa I Sci Rep. 2024; 14(1):23623.

PMID: 39384966 PMC: 11464914. DOI: 10.1038/s41598-024-74757-y.


Differential modulation of cell morphology, migration, and Neuropilin-1 expression in cancer and non-cancer cell lines by substrate stiffness.

Vela-Alcantara A, Santiago-Garcia J, Barragan-Palacios M, Leon-Chacon A, Dominguez-Pantoja M, Barceinas-Davila I Front Cell Dev Biol. 2024; 12:1352233.

PMID: 38903533 PMC: 11188430. DOI: 10.3389/fcell.2024.1352233.


Cell Immortality: Effective Techniques to Achieve and Investigate Its Applications and Challenges.

Chalak M, Hesaraki M, Mirbahari S, Yeganeh M, Abdi S, Rajabi S Life (Basel). 2024; 14(3).

PMID: 38541741 PMC: 10971253. DOI: 10.3390/life14030417.


Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient.

Valentine H, Aiken W, Morrison B, Zhao Z, Fowle H, Wasserman J Cancer Res Commun. 2023; 2(11):1355-1371.

PMID: 36643868 PMC: 9836004. DOI: 10.1158/2767-9764.crc-22-0245.


Strategies for immortalisation of amnion-derived mesenchymal and epithelial cells.

Ansari A, Denton K, Lim R Cell Biol Int. 2022; 46(12):1999-2008.

PMID: 35998259 DOI: 10.1002/cbin.11892.